Skip to main content

Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

  • 1st Edition, Volume 15-3 - September 23, 2011
  • Author: Fred Poordad
  • Language: English
  • Hardback ISBN:
    9 7 8 - 1 - 4 5 5 7 - 1 1 0 7 - 9

Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical… Read more

Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote
Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like naïve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient.